Data_Sheet_1_Differential Metabolism of Medium-Chain Fatty Acids in Differentiated Human-Induced Pluripotent Stem Cell-Derived Astrocytes.pdf
Medium-chain triglyceride (MCT) ketogenic diets increase ketone bodies, which are believed to act as alternative energy substrates in the injured brain. Octanoic (C8:0) and decanoic (C10:0) acids, which produce ketone bodies through β-oxidation, are used as part of MCT ketogenic diets. Although the ketogenic role of MCT is well-established, it remains unclear how the network metabolism underlying β-oxidation of these medium-chain fatty acids (MCFA) differ. We aim to elucidate basal β-oxidation of these commonly used MCFA at the cellular level. Human-induced pluripotent stem cell-derived (iPSC) astrocytes were incubated with [U-13C]-C8:0 or [U-13C]-C10:0, and the fractional enrichments (FE) of the derivatives were used for metabolic flux analysis. Data indicate higher extracellular concentrations and faster secretion rates of β-hydroxybutyrate (βHB) and acetoacetate (AcAc) with C8:0 than C10:0, and an important contribution from unlabeled substrates. Flux analysis indicates opposite direction of metabolic flux between the MCFA intermediates C6:0 and C8:0, with an important contribution of unlabeled sources to the elongation in the C10:0 condition, suggesting different β-oxidation pathways. Finally, larger intracellular glutathione concentrations and secretions of 3-OH-C10:0 and C6:0 were measured in C10:0-treated astrocytes. These findings reveal MCFA-specific ketogenic properties. Our results provide insights into designing different MCT-based ketogenic diets to target specific health benefits.
History
References
- https://doi.org//10.1016/j.freeradbiomed.2009.06.017
- https://doi.org//10.3389/fnene.2011.00005
- https://doi.org//10.1177/0271678X16684154
- https://doi.org//10.1080/17460441.2016.1245286
- https://doi.org//10.1111/j.1471-4159.1991.tb11435.x
- https://doi.org//10.1177/0271678X18808947
- https://doi.org//10.1046/j.1471-4159.1995.65062450.x
- https://doi.org//10.3233/JAD-141074
- https://doi.org//10.1093/brain/awv325
- https://doi.org//10.3233/JAD-180202
- https://doi.org//10.1111/nyas.12999
- https://doi.org//10.1111/j.1471-4159.2009.05859.x
- https://doi.org//10.1523/JNEUROSCI.23-13-05928.2003
- https://doi.org//10.1002/jnr.490180407
- https://doi.org//10.1113/JP273185
- https://doi.org//10.1007/BF03165404
- https://doi.org//10.1111/j.1471-4159.2008.05460.x
- https://doi.org//10.1016/j.neuroscience.2007.03.001
- https://doi.org//10.1093/nar/gkw1092
- https://doi.org//10.1093/nar/28.1.27
- https://doi.org//10.1093/nar/gkv1070
- https://doi.org//10.1111/epi.13833
- https://doi.org//10.1016/j.seizure.2016.01.011
- https://doi.org//10.1074/jbc.M111.294785
- https://doi.org//10.1093/bioinformatics/bts127
- https://doi.org//10.1016/0003-9861(78)90171-6
- https://doi.org//10.1016/S1474-4422(08)70092-9
- https://doi.org//10.1016/j.neurobiolaging.2013.11.027
- https://doi.org//10.3389/fnins.2016.00156
- https://doi.org//10.1194/jlr.R046706
- https://doi.org//10.1016/S0197-4580(03)00087-3
- https://doi.org//10.1371/journal.pcbi.1004808
- https://doi.org//10.1017/S0007114511003874
- https://doi.org//10.1177/0271678X16629482
- https://doi.org//10.3389/fnins.2017.00288
- https://doi.org//10.1002/glia.23259
- https://doi.org//10.1177/0271678X16659498
- https://doi.org//10.1096/fj.201500182
- https://doi.org//10.1111/j.1471-4159.1972.tb01389.x
- https://doi.org//10.1042/bst0290250
- https://doi.org//10.1016/j.pnpbp.2014.10.013
- https://doi.org//10.1002/nbm.850